While Mounjaro has shown promising results, it is still a newer product with relatively limited market penetration compared to the more established options from Novo
2022, 18 (1), e1009818 10.1371/journal.pcbi.1009818
Whether youre on it, curious about it, or actively trying to avoid it, youve probably wondered the same thing: if GLP-1 is a hormone your body already makes, is there a way to produce more of it without a prescription
13098_2025_1877_MOESM1_ESM.docx (download DOCX Supplementary Material 1 Supplementary Table 1: PRISMA 2020 Checklist, Supplementary Table 2 Search strategy, Supplementary Table 3 List of Exclusion Reports, Supplementary Table 3: Details of adverse reactions, Supplementary Tabel 4: GRADE Summary of Skeletal Muscle Mass Changes in Type 2 Diabetes with Sarcopenia Receiving GLP-1 Receptor Agonist: Systematic Review and Meta-analysis, Supplementary Table 5 List of Exclusion Reports, Supplementary Table 6 Basic characteristics of GLP-1 Receptor Agonist preparations
10.1042/BSR20190109 20 MohlerM
Who can I call